These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Biomarkers: Our Path Towards a Cure for Alzheimer Disease. Tarawneh R Biomark Insights; 2020; 15():1177271920976367. PubMed ID: 33293784 [TBL] [Abstract][Full Text] [Related]
43. A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study. Boada M; López OL; Olazarán J; Núñez L; Pfeffer M; Paricio M; Lorites J; Piñol-Ripoll G; Gámez JE; Anaya F; Kiprov D; Lima J; Grifols C; Torres M; Costa M; Bozzo J; Szczepiorkowski ZM; Hendrix S; Páez A Alzheimers Dement; 2020 Oct; 16(10):1412-1425. PubMed ID: 32715623 [TBL] [Abstract][Full Text] [Related]
44. Incident prolonged QT interval in midlife and late-life cognitive performance. Suemoto CK; Gibbons LE; Thacker EL; Jackson JD; Satizabal CL; Bettcher BM; Launer L; Phillips C; White LR; Power MC PLoS One; 2020; 15(2):e0229519. PubMed ID: 32097438 [TBL] [Abstract][Full Text] [Related]
45. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease. Dickie DA; Quinn TJ; Dawson J Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568 [TBL] [Abstract][Full Text] [Related]
46. A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease. Denver P; D'Adamo H; Hu S; Zuo X; Zhu C; Okuma C; Kim P; Castro D; Jones MR; Leal C; Mekkittikul M; Ghadishah E; Teter B; Vinters HV; Cole GM; Frautschy SA Front Physiol; 2019; 10():1269. PubMed ID: 31708792 [TBL] [Abstract][Full Text] [Related]
47. The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals. Wennberg AM; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Machulda MM; Petrucelli L; Mielke MM; Jack CR; Knopman DS; Parisi JE; Petersen RC; Dickson DW; Josephs KA Neurobiol Aging; 2019 May; 77():26-36. PubMed ID: 30776649 [TBL] [Abstract][Full Text] [Related]
48. Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: Implications for chronic neurodegeneration. Glushakova OY; Glushakov AA; Wijesinghe DS; Valadka AB; Hayes RL; Glushakov AV Brain Circ; 2017; 3(2):87-108. PubMed ID: 30276309 [TBL] [Abstract][Full Text] [Related]
49. Mixed dementia: A review of the evidence. Custodio N; Montesinos R; Lira D; Herrera-Pérez E; Bardales Y; Valeriano-Lorenzo L Dement Neuropsychol; 2017; 11(4):364-370. PubMed ID: 29354216 [TBL] [Abstract][Full Text] [Related]
50. Hippocampal Neurodegenerative Pathology in Post-stroke Dementia Compared to Other Dementias and Aging Controls. Akinyemi RO; Allan LM; Oakley A; Kalaria RN Front Neurosci; 2017; 11():717. PubMed ID: 29311794 [TBL] [Abstract][Full Text] [Related]
51. Vascular cognitive impairment (VCI): Progress towards knowledge and treatment. Di Legge S; Hachinski V Dement Neuropsychol; 2010; 4(1):4-13. PubMed ID: 29213654 [TBL] [Abstract][Full Text] [Related]
52. Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats. Goel R; Bhat SA; Hanif K; Nath C; Shukla R Mol Neurobiol; 2018 Feb; 55(2):1725-1739. PubMed ID: 28215000 [TBL] [Abstract][Full Text] [Related]
53. Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Raman MR; Kantarci K; Murray ME; Jack CR; Vemuri P Alzheimers Dement (Amst); 2016; 5():5-14. PubMed ID: 28054023 [TBL] [Abstract][Full Text] [Related]
55. Differential associations between systemic markers of disease and cortical thickness in healthy middle-aged and older adults. Coutinho AM; Coutu JP; Lindemer ER; Rosas HD; Rosen BR; Salat DH Neuroimage; 2017 Feb; 146():19-27. PubMed ID: 27847345 [TBL] [Abstract][Full Text] [Related]
56. The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease. Kim J; Schweizer TA; Fischer CE; Munoz DG J Alzheimers Dis; 2017; 55(1):381-389. PubMed ID: 27662301 [TBL] [Abstract][Full Text] [Related]
58. Exposure to air pollution as a potential contributor to cognitive function, cognitive decline, brain imaging, and dementia: A systematic review of epidemiologic research. Power MC; Adar SD; Yanosky JD; Weuve J Neurotoxicology; 2016 Sep; 56():235-253. PubMed ID: 27328897 [TBL] [Abstract][Full Text] [Related]
59. "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). Nelson PT; Trojanowski JQ; Abner EL; Al-Janabi OM; Jicha GA; Schmitt FA; Smith CD; Fardo DW; Wang WX; Kryscio RJ; Neltner JH; Kukull WA; Cykowski MD; Van Eldik LJ; Ighodaro ET J Neuropathol Exp Neurol; 2016 Jun; 75(6):482-98. PubMed ID: 27209644 [TBL] [Abstract][Full Text] [Related]
60. White matter hyperintensities and imaging patterns of brain ageing in the general population. Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]